Academic drug discovery centres: The economic and organisational sustainability of an emerging model

Drug Discovery Today

Volumn 19, Issue 11, 2014, Pages 1699-1710

  Schultz Kirkegaard, Henriette ^a   Valentin, Finn ^b  

^a Danish Medical Device Industry Association   (Denmark)

^b Department of International Economics and Management   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG DEVELOPMENT; DRUG INDUSTRY; ECONOMICS; FINANCIAL MANAGEMENT; FUNDING; NEGLECTED DISEASE; PROGRAM SUSTAINABILITY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; UNIVERSITY;

DRUG DISCOVERY; MODELS, ORGANIZATIONAL; UNIVERSITIES;

EID: 84910630218     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.06.011     Document Type: Review

References (31)

1. F. Pammolli The productivity crisis in pharmaceutical R&D Nat. Rev. Drug Discov. 10 2011 428 438
2. S. Finkbeiner Bridging the valley of death of therapeutics for neurodegeneration Nat. Med. 16 2010 1227 1232
3. A.J. Ivinson University investment in drug discovery Science 310 2005 777
4. C.J. Tralau-Stewart Drug discovery: new models for industry-academic partnerships Drug Discov. Today 14 2009 95 101
5. S. Frye US academic drug discovery Nat. Rev. Drug Discov. 10 2011 409 410
6. P.G. Wyatt The emerging academic drug-discovery sector Future Med. Chem. 1 2009 1013 1017
7. M. Ohlmeyer, and M. Zhou Integration of small-molecule discovery in academic biomedical research Mt. Sinai J. Med. 77 2010 350 357
8. C. Tralau-Stewart UK academic drug discovery Nat. Rev. Drug Discov. 13 2014 15 16
9. M. Everts The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery Pharm. Res. 28 2011 1454 1459
10. J. Kotz Small (molecule) thinking in academia SciBX 4 2011 10.1038/scibx.2011.617
11. P. Vallance The future is much closer collaboration between the pharmaceutical industry and academic medical centers Clin. Pharmacol. Ther. 87 2010 525 527
12. J. Hunter Precompetitive collaboration in the pharmaceutical industry S. Ekins, Collaborative Computational Technologies for Biomedical Research 2011 Wiley and Sons 55 84
13. M.W. Freeman, and A.P. Dervan The path from bench to bedside: considerations before starting the journey J. Invest. Med. 58 2011 746 751
14. T. Melese Open innovation networks between academia and industry: an imperative for breakthrough therapies Nat. Med. 15 2009 502 507
15. G.J. Brewer Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required J. Invest. Med. 54 2006 291 302
16. J. Hudson, and H.F. Khazragui Into the valley of death: research to innovation Drug Discov. Today 18 2013 610 613
17. A.S. Verkman Drug discovery in academia Am. J. Physiol. 286 2004 465 474
18. J.A. Frearson, and I.T. Collie HTS and hit finding in academia - from chemical genomics to drug discovery Drug Discov. Today 14 2009 1150 1158
19. J.A. Frearson, and C.A. Wyatt Drug discovery in academia: the third way? Expert Opin. Drug Discov. 5 2010 909 919
20. L.G. Zucker, and M.R. Darby Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry Proc. Natl. Acad. Sci. U. S. A. 93 1996 12709 12716
21. G.P. Pisano Science Business 2006 Harvard Business School Press
22. G.P. Pisano The evolution of science-based business: innovating how we innovate Ind. Corp. Change 19 2010 465 482
23. J.A.C. Baum, and B.S. Silverman Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups J. Business Venturing 19 2004 411 436
24. W.W. Powell The spatial clustering of science and capital: accounting for biotech firm-venture capital relationships Reg. Studies 36 2002 291 305
25. A.L. Sherwood, and J.G. Covin Knowledge acquisition in university-industry alliances: an empirical investigation from a learning theory perspective J. Prod. Innov. Manag. 25 2008 162 179
26. A. Arora Markets for Technology and Their Implications for Corporate Strategy 2001 MIT Press
27. R. Lowe Who develops a university invention? The impact of tacit knowledge and licensing policies J. Technol. Transf. 31 2006 415 429
28. S. Hoelder Discovery of small molecule cancer drugs: successes, challenges and opportunities Mol. Oncol. 6 2012 155 176
29. P. Dasgupta, and P.A. David Toward a new economics of science Res. Policy 23 1994 487 521
30. R.K. Merton Priorities in scientific discovery: a chapter in the sociology of science Am. Sociol. Rev. 22 1957 635 659
31. J. Owen-Smith A comparison of U.S. and European university-industry relations in the life sciences Manage. Sci. 48 2002 24 43